“Securing a patent in Australia is a strategic achievement for Mucocort AB and a crucial step in our efforts to establish a presence in a key market. This strengthens our global position and unlocks new growth opportunities,” says Jean Lycke, Project Manager at Mucocort AB.
The patent grants Mucocort AB exclusive rights in the Australian market, known for its advanced healthcare sector. It also paves the way for strategic collaborations with leading medtech companies, further accelerating the company’s expansion and market presence.
Mucocort is part of and receives business support from Umeå Biotech Incubator.